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Background: Erythromycin is a medically important antibiotic, biosynthesized by the actinomycete
Saccharopolyspora erythraea. Genes encoding erythromycin biosynthesis are organized in a gene cluster, spanning
over 60 kbp of DNA. Most often, gene clusters encoding biosynthesis of secondary metabolites contain regulatory
genes. In contrast, the erythromycin gene cluster does not contain regulatory genes and regulation of its
biosynthesis has therefore remained poorly understood, which has for a long time limited genetic engineering
approaches for erythromycin yield improvement.
Results: We used a comparative proteomic approach to screen for potential regulatory proteins involved in
erythromycin biosynthesis. We have identified a putative regulatory protein SACE_5599 which shows
significantly higher levels of expression in an erythromycin high-producing strain, compared to the wild type
S. erythraea strain. SACE_5599 is a member of an uncharacterized family of putative regulatory genes, located in
several actinomycete biosynthetic gene clusters. Importantly, increased expression of SACE_5599 was observed
in the complex fermentation medium and at controlled bioprocess conditions, simulating a high-yield industrial
fermentation process in the bioreactor. Inactivation of SACE_5599 in the high-producing strain significantly
reduced erythromycin yield, in addition to drastically decreasing sporulation intensity of the SACE_5599-inactivated
strains when cultivated on ABSM4 agar medium. In contrast, constitutive overexpression of SACE_5599 in the wild
type NRRL23338 strain resulted in an increase of erythromycin yield by 32%. Similar yield increase was also
observed when we overexpressed the bldD gene, a previously identified regulator of erythromycin biosynthesis,
thereby for the first time revealing its potential for improving erythromycin biosynthesis.
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Conclusions: SACE_5599 is the second putative regulatory gene to be identified in S. erythraea which has positive
influence on erythromycin yield. Like bldD, SACE_5599 is involved in morphological development of S. erythraea,
suggesting a very close relationship between secondary metabolite biosynthesis and morphological differentiation
in this organism. While the mode of action of SACE_5599 remains to be elucidated, the manipulation of this gene
clearly shows potential for improvement of erythromycin production in S. erythraea in industrial setting. We have
also demonstrated the applicability of the comparative proteomics approach for identifying new regulatory
elements involved in biosynthesis of secondary metabolites in industrial conditions.
Keywords: Saccharopolyspora erythraea, Erythromycin, Polyketide, Regulator, SACE_5599, lmbU, Differentiation,
Sporulation, Strain improvement, Metabolic engineeringIntroduction
Actinomycetes are an evolutionary diverse group of bac-
teria, predominantly soil-inhabiting organisms with GC-
rich genomes and complex life cycles. Most actinomycetes
are characterized by mycelial growth, multicellular behav-
iour, complex physiological and morphological differenti-
ation and highly regulated biosynthesis of secondary
metabolites with a broad spectrum of biological activities.
Many of these natural products are of enormous industrial
and clinical importance, e.g. as antiinfectives, anti-cancer
agents and immunosuppressants. Soil-dwelling actinomy-
cetes grow as vegetative mycelia of branching hyphae
which explore the environment for available nutrients.
When nutrients become scarce, for example after a few
days of growth on an agar plate, aerial hyphae emerge
from the colony into the air using the lysed vegetative my-
celium as substrate [1,2]. Typically, antibiotic biosynthesis
is initiated at this time [3]. Aerial hyphae then undergo
several morphological stages, leading to subdivision of ap-
ical cells and finally to the release of spores [2]. These dif-
ferentiation steps as well as biosynthesis of bioactive
compounds (secondary metabolites) are coordinated by
the complex regulatory pathways, which have been so far
mostly studied in model actinomycetes, such as Strepto-
myces coelicolor. Important roles of some of the identified
genes in differentiation, predominantly genes with regula-
tory function, have been elucidated based on the classical
genetic studies. The obtained mutants, deficient in differ-
entiation mainly fall into two phenotypic categories: mu-
tants with “Bld” (bald) phenotype, which fail to make
aerial mycelium and the “Whi” (white) mutants, which
can form aerial mycelium but cannot produce spores and
the spore pigment (reviewed in [2]).
Saccharopolyspora erythraea is an important filament-
ous actinomycete used in industrial fermentation processes
for production of erythromycin, a medically important
polyketide antibiotic. Semi-synthetic derivatives of erythro-
mycin, such as clarithromycin and azithromycin, are widely
used in clinical setting to treat infections caused by Gram-
positive pathogens. In addition to its industrial importance,
S. erythraea has been used as a model actinomycete systemfor studying the biosynthesis of secondary metabolites of
polyketide origin, particularly the macrolide antibiotics,
synthesized by modular type I polyketide synthase (PKS)
genes [4,5]. Basic structure of the erythromycin biosynthetic
gene cluster was found to span over 60 kbp of DNA and to
comprise 20 genes transcribed in four main polycistronic
units [6]. Three centrally located large PKS genes eryAI,
eryAII and eryAIII, involved in the biosynthesis of macro-
lide core (6-deoxyerythronolide B), are flanked on both
sides by the genes involved in post-PKS processing, biosyn-
thesis and attachment of desosamine and mycarose sugar
moieties to the erythronolide aglycone and erythromycin
resistance [7,8]. Reflecting its industrial and scientific im-
portance, the genome of S. erythraea wild type (WT) NRRL
23338 strain has been sequenced recently [8]. With the aim
of achieving higher erythromycin productivity and fermen-
tation processes scalable to industrial-scale bioreactors, the
WT strain and the corresponding bioprocess have been im-
proved for decades mainly by iterative methods of random
mutagenesis and selection, resulting in industrial high-
producing strains [9,10]. Due to very high industrial im-
portance of erythromycin, the efforts towards improved S.
erythraea strains are continuing by genetic/metabolic en-
gineering as well as classical methods, assisted by genomic
and transcriptomic approaches [9,11-13].
In most actinomycetes, timely and coordinated expres-
sion of large genetic clusters for polyketide biosynthesis,
essential for efficient biosynthesis of the corresponding
bioactive compounds, is achieved by several levels of regu-
latory control. First, pleiotropic (globally acting) regulatory
genes, link signals from the environmental stimuli and life
cycle progression to the biosynthetic machinery of the
strain. Pleiotropic regulators are thought to activate tran-
scription of pathway-specific regulatory genes, most often
located inside biosynthetic gene clusters [14]. Pathway-
specific regulators, such as the SARP (Streptomyces anti-
biotic regulatory protein) family regulators or the LAL
(large ATP-binding regulators of the LuxR family) family
regulators [15-17] then coordinate transcription of the
biosynthetic genes most often located inside the corre-
sponding clusters. In several actinomycetes engineering of
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for increasing yields of natural products [18]. In some
cases pathway-specific regulatory genes, naturally present
in the biosynthetic gene clusters, have been overexpressed
using strong constitutive promoters. In one example, over-
expression of tylS and tylR regulatory genes in WT as well
as in industrial overproducing strains of Streptomyces fra-
diae resulted in a significant increase in yields of tylosin, a
macrolide antibiotic structurally related to erythromycin
[19]. Similarly, yields of the immunosuppressants rapamy-
cin and FK506 have been successfully increased by overex-
pression of the pathway-specific regulatory genes rapG
(and rapH) in Streptomyces rapamycinicus and fkbN in
Streptomyces tsukubaensis, respectively [20,21].
In striking contrast to the predominant regulatory cas-
cade, present in most actinomycetes, the erythromycin gene
cluster in S. erythraea does not contain pathway-specific
regulatory genes, which has for some time precluded a bet-
ter understanding of the regulatory mechanisms governing
erythromycin biosynthesis. Importantly, microarray-based
transcriptional studies revealed coordinated expression of
most erythromycin biosynthetic genes and therefore the
very likely existence of a common regulator for the ery clus-
ter [12]. It was later demonstrated that this function can be
carried out directly by BldD, a global regulatory protein
with a key role in S. erythraea morphological differenti-
ation. BldD was found to bind with a high affinity to all five
promoter regions of the ery cluster, and the inactivation of
the bldD gene reduced erythromycin production 7-fold in
the WT strain of S. erythraea. In addition, bldD inactivation
resulted in the Bld phenotype [22], analogously to the better
characterized role of the bldD orthologue in S. coelicolor
[23,24].
Based on a comparative proteomic approach and tran-
scriptional analysis, carried out in the industrial cultivation
conditions, we have identified a novel putative regulatory
gene SACE_5599, which shows significantly higher expres-
sion levels in an industrial high producing strain of S. ery-
thraea, ABE1441, compared to the WT strain. SACE_5599
is homologous to the putative regulatory genes located in
several biosynthetic gene clusters of actinomycetes and its
overexpression in S. erythraea NRRL23338 resulted in an
enhanced erythromycin production (32% increased titre) at
the shaker level, while its inactivation in the industrial
strain led to significantly lower erythromycin yield, accom-
panied by a drastic reduction of sporulation on solid agar
medium. Advancing our understanding of the regulation of
erythromycin biosynthesis is of key importance as it will
likely contribute towards increased efficiency of industrial
fermentations of S. erythraea and potentially other indus-
trial antibiotic-producing actinomycetes. In addition, this
work demonstrates the potential of omics approaches for
strain development in the industrial setting when analyses
are carried out in industrially relevant conditions.Results
Identification of differentially expressed protein
SACE_5599
Regulatory mechanisms that control S. erythraea life cycle
and erythromycin biosynthesis remain poorly characterized,
which limits the genetic engineering efforts towards im-
proved strains with increased yields of erythromycin. Based
on the genome sequencing data more than 1000 genes with
putative regulatory function are encoded in the S. erythraea
genome [8]. However, their possible role in the life cycle or
secondary metabolism is hard to predict based on the gen-
ome sequence alone. With the aim of identifying potential
regulatory elements involved in regulation of erythromycin
production during the fermentation process, we employed
a comparative proteomic approach. We invested significant
efforts to develop media from which high quality proteome
and transcriptome data could be generated, at the same
time ensuring relatively high yield of erythromycin, and
maintaining key process conditions comparable with the
industrial large scale fermentation process. Two S. ery-
thraea strains, the WT NRRL23338 strain and an industrial
erythromycin high-producing ABE1441 strain, developed
from the WT strain through an intensive strain improve-
ment program, were cultivated at 5 L bioreactor scale in
medium and fermentation conditions simulating industrial
fermentation process for production of erythromycin. In
these conditions the NRRL23338 strain typically produces
less than 100 mg/L erythromycin, whereas the ABE1441
strain produces approx. 2000 mg/L erythromycin (Figure 1).
Representative samples of complete fermentation broths
were collected at multiple time points during the erythro-
mycin fermentation, cell-free protein extracts of S. erythraea
were prepared and subjected to quantitative proteomic ana-
lysis. Relative quantification was performed using the spec-
tral counting methodology, which compares numbers of
detected MS/MS spectra for each of identified proteins [25].
In this way we aimed to identify regulatory proteins
showing significant difference in expression levels at dif-
ferent stages (physiological conditions) of the fermentation
process. It was our goal to obtain a small number of
promising candidate regulatory proteins that could be fur-
ther evaluated by gene inactivation and overexpression ex-
periments with the final aim of increasing erythromycin
yield through genetic engineering approaches. Interest-
ingly, in addition to over 20-fold higher erythromycin yield
achievable by the industrial strain, the WT and ABE1441
strains also differ significantly in intensity of sporulation
on the ABSM4 and R5 agar media (Figure 2; Additional
file 1), similarly to what has been previously observed for
other erythromycin high-producing strains [9]. The high-
producing strain ABE1441 showed abundant sporulation
on ABSM4 agar plates (used in this study for inoculation
of liquid media) whereas the NRRL23338 sporulates
poorly and only after prolonged cultivation period.
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Figure 1 Relative expression of SACE_5599 and erythromycin
biosynthesis of the WT and industrial high-producing ABE1441
strains. Data from one representative fermentation process are
shown, normalized to expression of 16S rRNA. Grey lines represent
relative expression of SACE_5599 ( ) and erythromycin
concentration ( ) in the ABE1441 strain. Black lines represent
relative expression of SACE_5599 ( ) and erythromycin
concentration ( ) in the WT strain.
Figure 2 Phenotypes of S. erythraea mutants with inactivated
or in trans - overexpressed SACE_5599 on ABSM4 agar plates
containing apramycin: A) NRRL23338/pSET152; B) ABE1441/
pSET152; C) ABE1441/ΔSACE_5599 complemented with
SACE_5599 (pABE110; pABE112); D) ABE1441/ΔSACE_5599
(pABE110); E) ABE1441/pSET152 + SACE_5599 (pABE104) F)
NRRL23338/pSET152 + SACE_5599 (pABE104). Construction of
plasmid constructs is presented in Table 1. Equivalent result was
observed when plates without apramycin were used (not shown).
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of intense erythromycin biosynthesis (35 h for the WTand
27 h for the ABE1441 strain), SACE_5599 was identified
as the putative regulatory protein with the most promin-
ent difference in expression levels when comparing the in-
dustrial and WT strains. In fact, peptides derived from
this protein were undetectable in protein extracts of the
NRRL23338 WT strain, whereas several peptides of the
SACE_5599 protein showed relatively high abundance
in samples of the industrial ABE1441 strain (Figure 3B,
Additional file 2).
SACE_5599 is a member of a so far uncharacterized
family of putative regulatory proteins
Based on these results it was our aim to investigate in
more detail the putative regulatory gene SACE_5599 and
its potential role in the regulation of erythromycin yield.
Genomic analysis revealed that the SACE_5599 gene is lo-
cated on the reverse strand at approx. position of 6.292
Mbp, inside the “non-core” region, believed to mainly con-
tain genes related to conditionally adaptive functions [8].
Nevertheless, SACE_5599 lies very close to the limit of the
predicted “core” region of S. erythraea chromosome [8]
and is located 2.7 Mbp away from the ery cluster on 8.2
Mbp chromosome, surrounded by genes with no apparent
role in erythromycin biosynthesis or secondary metabol-
ism (Figure 3A). Similarly, the bldD (SACE_2077) regulator
of transcription of erythromycin biosynthetic genes is also
encoded relatively far away from the ery cluster and is lo-
cated close to the other limit of “core” and “non-core” re-
gions in the circular S. erythraea chromosome (Figure 3A).Interestingly, both the SACE_5599 and bldD lie approx. 2
Mbp from oriC in opposite directions. Importantly, the
genome sequences of NRRL23338 and ABE1441 are identi-
cal inside the ORF and putative promoter region of
SACE_5599 as well as of the adjacent genes (ŠF, HP, GK -
unpublished results). SACE_5599 ORF was originally pre-
dicted at the time of S. erythraea genome annotation [8],
however, an additional upstream start codon can also be
envisioned, resulting in the length of the ORF of 184 or 219
amino acids, respectively (Figure 3B).
In addition to examining the genomic context, it was our
aim to obtain more information about the possible func-
tion of SACE_5599 by identifying its potentially better
characterized gene homologues in related bacterial species.
A BlastP search [26] in the ‘nr’ database of NCBI identified
a family of 29 thus far sequenced homologues with the E
value < 10-5, nearly all of them located inside antibiotic
gene clusters in the genomes of Actinomycetales. The
length of predicted polypeptide chains of most homologues
varies between 180 and 250 aa. The first member to be se-
quenced was the lmbU gene from the lincomycin biosyn-
thetic gene cluster from Streptomyces lincolnensis. The
lmbU gene contains a TTA codon in its nucleotide se-
quence and was therefore assigned a putative regulatory
function [27]. The TTA leucine-encoding codon is ex-
tremely rare in actinomycetes and is often involved in syn-
chronized regulation of expression of differentiation and
Figure 3 Genomic context and amino acid sequence of SACE_5599. A) Chromosomal locus of SACE_5599. Genes located close to
SACE_5599 and their putative functions are indicated. SACE numbers are indicated above the arrows. SACE_5596 encodes a hypothetical protein
with no similarity to other proteins in sequence databases. The position of SACE_5599 in S. erythraea genome is schematically represented. The
»core« region is marked with bold grey line and the »non-core« region with thin black line. B) Sequence of the 219 amino acid ORF of
SACE_5599 with peptides detected in proteomic analysis underlined, conserved tryptophan residues marked in bold and the position of
alternative translation start (184 aa variant) is shaded in grey.
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pression of the corresponding BldA-tRNA [2]. Sequence
alignment of the homologues reveals a series of strikingly
conserved tryptophan residues as well as numerous con-
served arginine residues (arginine amounts to 14.2% of all
amino acid residues of SACE_5599) in the N-terminal and
central part of the protein (Figure 3B, Additional file 3).
Theoretically predicted pI of the protein is 9.9, suggesting
its possible function in nucleic acid binding. In addition,
secondary structure prediction algorithms [28] predict a
very high proportion of α-helical structure. Unfortunately,
none of the homologues of SACE_5599 have been charac-
terized so far at the biochemical or structural level, there-
fore little information is available on the roles and
mechanism (s) of action of this family of proteins. Never-
theless, the notion of regulatory role of this family of
proteins was further strengthened by gene-inactivation
experiments of the novE homologue, located inside the
biosynthetic gene cluster for novobiocin biosynthesis.
When novE, also containing a TTA codon, was inactivated
in Streptomyces spheroides NCIMB11891, the yield of no-
vobiocin was reduced from 37 mg/L to 1.5 mg/L [29].
Interestingly, the TTA leucine codon is not present in the
sequence of SACE_5599.qPCR analysis of SACE_5599 expression in NRLL 23338
and ABE1441 strains
In the next step we decided to compare in more detail the
expression of SACE_5599 gene in the WT and erythro-
mycin high-producing ABE1441 S. erythraea strains. We
carried out a bioprocess for production of erythromycin at
the scale of 5 L bioreactors, closely resembling industrial
conditions, and samples for RNA analysis were harvested
every 2 hours. Performing qPCR with SACE_5599-specific
oligonucleotide primers we confirmed that transcription
of SACE_5599 in the WT strain was very low throughout
the bioprocess duration, peaking at around 70 h. In ac-
cordance with the results of the proteomic analysis, the
expression of this gene was up to 20-fold higher in the
high producing ABE1441 strain, particularly at the later
stages of the cultivation process (Figure 1).
Inactivation of SACE_5599 in the industrial overproducing
strain of S. erythraea reduces erythromycin yield and has
profound effect on morphological development
The observed differences in expression levels of SACE_5599
between the two strains suggest that this gene might be in-
volved in the regulation of erythromycin biosynthesis of the
ABE1441 overproducing strain and, possibly, also in the
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strains (Additional file 1). However, in order to establish
whether there is a clear causative relationship between the
drastically different expression levels of SACE_5599 and
erythromycin yield we carried out the SACE_5599 gene in-
activation in the industrial overproducing strain ABE1441.
The pKC1132-based plasmid pABE110, containing 344 bp
of the central region of SACE_5599 and not capable of rep-
licating in S. erythraea was constructed and transferred into
S. erythraea by conjugation from E. coli, thereby inactivating
the putative regulatory gene by a single crossover gene dis-
ruption. The correct insertion through homologous recom-
bination into the SACE_5599 locus and interruption of the
ORF were confirmed by PCR and sequencing. 20 independ-
ent SACE_5599-inactivated ex-conjugants were obtained
and all of them showed a morphologically modified pheno-
type, compared with the parent ABE1441 strain. On the
ABSM4 solid medium, these mutant strains showed signifi-
cantly reduced sporulation, which was also delayed for sev-
eral days as compared to the original ABE1441 strain
(Figure 2). Moreover, the mutant strains with inactivated
SACE_5599 also produced substantially higher amounts of
an unknown black pigment when grown on ABSM4 agar.
Further on, we tested the obtained mutants for erythro-
mycin productivity in laboratory scale (shake flask level).
Inactivation of the SACE_5599 gene resulted in a signifi-
cant decrease (37%) in erythromycin yield in these mutant
strains, compared to the original ABE1441 overproducing
strain, which produced approx. 2.1 g/L erythromycin
under the cultivation conditions used (Figure 4). Clearly,
the decrease in erythromycin yield was not as drastic as to
drop to the yield observed in the WT strain (around 60–
70 mg/L) despite a complete lack of SACE_5599 expres-
sion in the SACE_5599-inactivated strains. Therefore, it0
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Figure 4 Yield of erythromycin produced by different mutant strains
Horizontal lines represent the median values and perpendicular lines indica
differences between experimental group samples compared to control sam
Methods. Panel A): Erythromycin production by NRRL23338 transformants,
control 2 NRRL23338 + pSET152; B: NRRL23338 + SACE_5599-219 aa (pABE1
BldD (pABE21). Panel B): Erythromycin production by industrial high-produ
method; ABE1441: control 1 ABE1441; E: control 2 ABE1441 + pSET152; F: A
SACE_5599-219 aa-HA (pABE112) sporulating strains; H: ABE1441 + SACE_55can be concluded that the effect of differential expression
of SACE_5599 on erythromycin yield in the high-
producing ABE1441 strain seems to represent one of sev-
eral factors, which contribute to increased erythromycin
yield and likely form a complex interdependent regula-
tory/metabolic network. At this point it is not possible to
speculate whether SACE_5599 is directly involved in tran-
scriptional regulation of the ery genes or the effect of
SACE_5599 on efficiency of erythromycin biosynthesis is
indirect, possibly acting through regulation of so far un-
identified metabolic/regulatory pathways, intimately asso-
ciated with the differentiation process.
Constitutive overexpression of SACE_5599 in the NRRL
23338 strain leads to erythromycin titre increase
Further on, it was our aim to evaluate whether overexpres-
sion of SACE_5599 in the WT S. erythraea strain can posi-
tively influence the regulatory network of the erythromycin
biosynthetic processes and potentially lead to the pheno-
type more similar to the ABE1441 high producing strain,
generated by strain improvement through random muta-
genesis, thus leading to higher erythromycin yields and im-
proved sporulation on ABSM4 agar medium. A set of
pSET152-based expression vectors was constructed and
used to integrate an additional copy of SACE_5599 in the
S. erythraea chromosome. Relatively strong constitutive
promoter PermE* was used in all cases to drive transcrip-
tion in trans. As SACE_5599 has not been previously char-
acterized or expressed in trans, eight different plasmid
construct variants were prepared (Table 1). The variations
were made in a) the 5’-UTR where variants with or with-
out a ribosomal binding site (RBS) between the PermE*
and the start codon were introduced, b) the SACE_5599
ORF to account for possible 184 aa or 219 aa ORF size,0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
ABE1441 E F* G H I
of S. erythraea. Bars encompass 95% of the sample population.
te extreme values (min, max). Asterisks denote statistically significant
ples. The data were analyzed using SAS/STAT program as described in
determined by the microbiological assay; WT: control 1 NRRL23338; A:
04); C: NRRL23338 + SACE_5599-219 aa-HA (pABE106); D: NRRL23338 +
cing strain ABE1441 transformants, determined by the HPLC-UV
BE1441 ΔSACE_5599 (pABE110); G: ABE1441 ΔSACE_5599 +
99-219 aa (pABE104); I: ABE1441 + BldD (pABE21).
Table 1 Strains and plasmids used in this study
Vector/strain name Description Promoter Gene Reference
S.erythraea WT- NRRL23338 / / [31,32]
S.erythraea ABE1441 / / Acies Bio
pABE53 ɸC31, apramycin PermE* without RBS SACE_5599 (184 aa) This work
pABE101 ɸC31, apramycin PermE* with RBS SACE_5599 (184 aa) This work
pABE102 ɸC31, apramycin PermE* without RBS SACE_5599 (184 aa) HA-tag This work
pABE103 ɸC31, apramycin PermE* with RBS SACE_5599 (184 aa) HA-tag This work
pABE104 ɸC31, apramycin PermE* without RBS SACE_5599 (219 aa) This work
pABE105 ɸC31, apramycin PermE* with RBS SACE_5599 (219 aa) This work
pABE106 ɸC31, apramycin PermE* without RBS SACE_5599 (219 aa ) HA-tag This work
pABE107 ɸC31, apramycin PermE* with RBS SACE_5599 (219 aa) HA-tag This work
pABE110 Suicide, apramycin / 344 bp long part of the SACE_5599 gene for disruption This work
pABE21 ɸC31, apramycin PermE* without RBS bldD gene This work
pABE112 ɸC31, thiostrepton PermE* without RBS SACE_5599 (219 aa ) HA-tag This work
Site-specific integration with bacteriophage ɸC31 integrase is indicated for pSET152-derived plasmids; “/” refers to “none or not applicable”.
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[30] was either absent or present, in order to be able to
confirm the functional in-trans expression of SACE_5599
by western blotting. Each generated transformant was sub-
jected to PCR analysis in order to confirm that the corre-
sponding plasmid construct was integrated into S. erythraea
genome by the action of ɸC31 integrase, encoded in the
pSET152 backbone. Integration through homologous re-
combination into the native copy of SACE_5599 was not
observed. In addition to the NRRL23338 WT strain, the
same plasmid constructs were also introduced into the high
producing ABE1441 strain in order to evaluate whether fur-
ther increase in erythromycin yield can be achieved (see
next section).
The obtained transformants of the NRRL23338 strain
were then cultivated in shake flasks. In order to evaluate
the suitability of the used vector/promoter system, cul-
tures were sampled after 72 h of cultivation (estimated
time of intense erythromycin biosynthesis in shake
flasks) and SACE_5599 transcript levels were evaluated
in strains transformed with different plasmids by qPCR.
As shown in Figure 5A, qPCR analysis revealed signifi-
cantly increased transcription levels in the transfor-
mants, constitutively overexpressing either 219 aa or 184
aa variant of SACE_5599, compared to the WT strain.
Interestingly, transcription levels in transformants of the
WT strain (with the second copy of SACE_5599 in trans
under PermE* promoter) were still relatively low com-
pared to the levels observed in the industrial high-
producing ABE1441 strain, also determined in this qPCR
analysis (Figure 5A). In order to confirm functional
expression of the SACE_5599 protein, cell free protein
extracts of the transformants with HA-tagged variants of
SACE_5599 were subjected to western blot analysis.Importantly, we could detect strong specific bands of
apparent molecular mass of (33 kDa) only in the sam-
ples in which longer variant of the gene was constitu-
tively expressed, either without (pABE106) or with RBS
(pABE107) in the 5’-UTR of the transcript (Figure 5B).
In contrast, the bands corresponding to the shorter 184 aa
variant (expressed from plasmids pABE102, pABE103)
were observed at the molecular mass of 25 kDa but were
very faint suggesting extremely low expression level. This
suggests that the 219 aa variant of SACE_5599 protein is
likely physiologically relevant. We hypothesize that the
shorter 184 aa polypeptide variant might fold much less
efficiently into a stable three-dimensional structure and is
more rapidly degraded. Further on, similar intensity of
the bands was observed in all 219 aa transformants, re-
gardless of whether 5’-UTR with or without RBS was
used (Figure 5B). The estimated molecular masses of
both HA-tagged variants are slightly larger than their
theoretically calculated values, possibly due to the very
high pI of SACE_5599.
In the next experiment, erythromycin yield was deter-
mined in fermentation broths of the NRRL23338 strain
transformants containing in trans copy of the longer 219
aa variant of SACE_5599 (plasmid pABE104) after 7 days
of cultivation. Transformants containing the plasmid
pABE106 with the HA-tagged version of SACE_5599 for
which high overexpression was confirmed by western blot,
were also included in the analysis. Erythromycin yield of
the WT-based strains was determined by the microbio-
logical assay based on Bacillus subtilis growth inhibition
(see Methods), considering that at low erythromycin con-
centrations (below 200 mg/L) the erythromycin present
in the broth cannot be reliably quantified by the used
HPLC method. Indeed, erythromycin yield in SACE_5599
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Figure 5 Evaluation of in-trans expression of SACE_5599 in
S.erythraea. A) qPCR analysis of expression levels of SACE_5599
(normalized to expression of 16S rRNA) in WT and strains with additional
copy of SACE_5599 (pABE53, pABE104), compared to the ABE1441
high-producing strain. B) Western blot analysis of in trans expression of
219 aa (lanes 2–5) and 184 aa (lanes 7–10) SACE_5599-HA and the
control NRRL23338 strain with pSET152 (lane 1). Molecular mass markers
were loaded in lane 6 and their positions are schematically presented on
the right side of the blot. Bands of apparent molecular mass of 33 kDa
are observed in 4 independent 219 aa transformants of the NRRL23338
strain, two containing the RBS sequence (pABE107) in the expression
vector (lanes 2–3) and two without the RBS sequence (pABE106) (lanes
4–5). A very weak band of apparent molecular mass of 25 kDa was
observed when shorter variant (184 aa) of SACE_5599 was expressed,
either without RBS (plasmid pABE102 – lanes 7 and 8) or with RBS
(plasmid pABE103 – lanes 9 and 10).
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(Figure 4) compared to the WT level and addition of HA-
tag to the C-terminus did not significantly influence the ef-
fect of SACE_5599 overexpression. It is noteworthy that
the yield increase as well as observed expression levels of
SACE_5599 are relatively low, although we used the con-
stitutive PermE* promoter, which has previously been dem-
onstrated as relatively strong promoter in S. erythraea [33].
Nevertheless, in this way we have clearly demonstrated
a positive influence of SACE_5599 overexpression on
erythromycin yield in the WT strain.
Complementation of the SACE_5599-inactivated
high-producing strain ABE1441
In parallel with in-trans expression in the NRRL23338
WT strain, we also introduced the 219 aa version of thegene SACE_5599 into the ABE1441 high producing strain,
as well as into the SACE_5599-inactivated mutant of
ABE1441. Interestingly, when SACE_5599 was over-
expressed in trans in the high producing ABE1441 strain,
using the plasmid pABE104, the yield of erythromycin was
not significantly increased (Figure 4), suggesting that the
underlying regulatory mechanisms have already been opti-
mized (improved) in this industrial strain through random
mutagenesis and selection procedures. Further on, one of
the 20 SACE_5599-inactivated strains of ABE1441 high
producing strain (see above) was complemented with the
longer 219 aa variant of the gene. In this case, a thiostrep-
ton resistance cassette was added to the pABE106 vector,
which was used for selection, because the apramycin resist-
ance marker is already present in the plasmid used for in-
activation of the native SACE_5599 copy (Table 1). Normal
sporulation phenotype, observed in the parent ABE1441
strain, was restored in about 80% of the ex-conjugants,
which had SACE_5599 disrupted strain and then comple-
mented in trans. Interestingly, erythromycin productivity
was restored to the levels of the ABE1441 high-producing
strain, which coincided with the recovery of original sporu-
lation capacity (Figure 4). In contrast, in strains which failed
to regain sporulation capacity, erythromycin yield also
remained at the level of SACE_5599-inactivated mutants. It
is important to stress that decreased yields of the strains
which did not sporulate on ABSM4 agar medium, were not
caused by poor growth/biomass formation, as evaluated by
the pH and packed cell volume (PCV) measurements of
vegetative media before inoculating the production media
(not shown). Therefore, the effect of SACE_5599 on
erythromycin biosynthesis seems to be closely related to its
role in morphological differentiation, similarly to what was
observed in the case of the bldD gene [22].
Moderate increase in erythromycin yield is achieved by
overexpression of BldD in S. erythraea NRRL23338
It was one of important objectives of our work to evaluate
the biotechnological potential of regulatory genes, known
to influence erythromycin yield, in an effort to obtain fur-
ther improved S. erythraea strains. Therefore, in parallel
with overexpression of the newly identified SACE_5599,
we also overexpressed in the NRRL 23338 strain the bldD
gene, for which the positive regulatory role in erythro-
mycin biosynthesis was demonstrated earlier [22]. For
expression of bldD we used the same vector-promoter sys-
tem (plasmid pABE21) as described above for expression
of SACE_5599 and fermentation was carried at shake flask
level as described above (Table 1). Indeed, bldD-overex-
pressing strains produced on average approx. 30% more
erythromycin compared to the wild type strain (Figure 4),
resulting in similar yield improvement as observed with
SACE_5599 overexpression. Interestingly, when bldD was
over-expressed in trans in the high producing ABE1441
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but in contrast, was slightly decreased compared to the
original ABE1441 strain (Figure 4).
Discussion
Improving the understanding of regulatory elements in-
volved in erythromycin biosynthesis in S. erythraea re-
mains a challenging task because no regulatory genes are
present inside the erythromycin gene cluster. Analogously
as demonstrated for bldD [22], other potential regulators
influencing erythromycin biosynthesis, might be located in
other regions of the chromosome of S. erythraea and
affect multiple physiological processes simultaneously, e.g.
morphological differentiation or other metabolic path-
ways, in addition to transcriptional control of erythro-
mycin biosynthetic genes. The difficulty of identifying key
regulatory genes, crucial for improvement of erythromycin
yield, is reflected by the fact that among about 7000 pre-
dicted ORFs in S. erythraea genome 15.5% are putative
regulatory genes [8]. Even a recent comparative genomic
analysis of the natural and industrial erythromycin over-
producing strain identified 40 genomic variations affecting
genes related to the regulation of transcription and trans-
lation processes [9].
In this work we have identified a putative regulatory
gene/protein SACE_5599, based on a comparative prote-
omic analysis of erythromycin high-producing ABE1441
and WT S. erythraea strains, cultivated in industrially
based medium. After bldD, SACE_5599 is only the second
putative regulatory gene identified to date to affect
erythromycin yield. This finding shows a promising poten-
tial of the non-gel based proteomic techniques to detect
and identify differentially expressed regulatory proteins,
which are generally of extremely low abundance. The re-
sults of gene inactivation and overexpression experiments
carried out in this work showed that this gene is indeed
involved in the increased yield of erythromycin in the in-
dustrial high-producing ABE1441 strain. In addition to de-
creasing erythromycin yield, inactivation of SACE_5599
also resulted in the morphological phenotype with drastic-
ally reduced sporulation of the resulting mutant strains.
While levels of expression of SACE_5599 are clearly re-
lated to erythromycin biosynthesis, an important question
remains about the mechanism of action of this putative
regulatory protein as well as of its homologues in other ac-
tinomycetes. Considering the high predicted pI value of
SACE_5599 and reports of putative regulatory roles of its
homologues in other actinomycetes it can be speculated
that SACE_5599 acts as transcriptional regulator by bind-
ing to specific DNA/RNA sequences [29].
Interestingly, a profound effect on morphological de-
velopment of S. erythraea was observed when bldD, the
first identified regulatory protein involved in the regula-
tion of erythromycin biosynthesis , was inactivated [22].Our results thus support the idea that the regulatory
network involved in morphological differentiation inter-
connects very closely with erythromycin biosynthesis.
Moreover, the propensity of aerial mycelium formation
seems to correlate well with erythromycin production
among spontaneously rifampicin-resistant mutants of the
NRRL23338 strain [34], suggesting that from the regula-
tion aspect, morphological differentiation and erythro-
mycin biosynthesis are very closely related phenomena. In
another recent study, the bld phenotype of bldD-inacti-
vated strains was shown to be overcome by inactivation of
the SACE_7040 gene, a regulator of the TetR family. Un-
fortunately, it was not reported whether re-established
morphological phenotype also led to the return of original
erythromycin yields in that double mutant strain [35]. An-
other recent study revealed the role of the SACE_0012
gene in morphological differentiation of S. erythraea, how-
ever, in this case, no significant change in erythromycin
productivity was observed in the SACE_0012-inactivated
strains in spite of the observed early aerial hyphae forma-
tion of this strain [36].
In an attempt to analyse how our results correlate with
the previous work of other groups in S. erythraea and to
gain a more comprehensive insight into the roles of
SACE_5599 and bldD, we took a closer look at the data of
recent high-throughput studies, carried out with S. ery-
thraea. In particular, we analysed how the transcription of
these two regulatory genes correlated with erythromycin
biosynthesis at different phases of cultivation. In most
studies in the past, cultivation of S. erythraea was carried
out in soluble non-industrial media. In contrast, we made
particular effort to develop media and bioprocess parame-
ters closely resembling the industrial conditions. Interest-
ingly, the SACE_5599 gene was one of the few genes that
were not included in the microarray design of most previ-
ous transcriptomic studies [9,12,34,37], therefore no infor-
mation is available about its expression profiles in these
studies. In contrast, transcription levels of bldD were stud-
ied in most of the published studies. In an initial attempt
to characterize transcriptional changes in S. erythraea WT
strain during different growth phases, the expression bldD
(SACE_2077) was found to decrease during transition from
initial growth phase (phase A) to growth slowdown phase
(phase B), similarly to expression of erythromycin biosyn-
thetic genes [37]. However, when the same transcriptome
data was later reinterpreted the bldD gene was not catego-
rized into the same co-transcriptional module as the
erythromycin biosynthetic cluster [38]. Interestingly, when
different rifampicin-resistant mutants of S. erythraea were
later profiled by DNA-microarrays, bldD transcription
levels were lower in strains with higher transcription of
erythromycin biosynthetic genes and increased erythro-
mycin yield [34]. Moreover, in this study bldD levels were
higher in strains with decreased erythromycin yield,
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pression and erythromycin yield. In contrast, a spontaneous
streptomycin-resistant mutant containing a mutation in the
rpsL gene (encoding the S12 ribosomal protein) showed a
markedly increased erythromycin yield which correlated
with an increased BldD expression at the late stages of the
bioprocess [39]. In a further comparative study transcrip-
tional profiles of the NRRL23338 and an erythromycin
overproducing Px strain were evaluated [9]. In this study
the erythromycin-overproducing strain showed higher
levels of bldD transcription compared to the WT in the ini-
tial phases of the fermentation process. However, after 35 h
bldD transcript levels were comparable in both strains,
whereas most prominent differences in erythromycin prod-
uctivity between the two strains were observed between the
48 h and 72 h time point. An RNASeq analysis of S. ery-
thraea transcriptome was also carried out recently, which
permitted us to analyse expression of SACE_5599 as well as
bldD. Indeed, transcription of some of the genes from the
erythromycin cluster was found to correlate well with
SACE_5599, while no correlation was apparent with bldD
[40]. During the preparation of this manuscript, another
comparative genomic and transcriptomic analysis of the
WT and high-producing S. erythraea E3 strain was re-
ported [41]. Importantly, industrial growth media were
used for S. erythraea cultivation in this study and
SACE_5599 was included in the microarray design. Simi-
larly to our observations SACE_5599 showed significantly
higher expression levels in the high producing strain, com-
pared to the WT in all time points of the fermentation
process. In contrast BldD expression was significantly de-
creased in the high producing strain.
In summary, different studies report different degree of
correlation between expression levels of either bldD or
SACE_5599 and erythromycin biosynthesis. There are at
least three possible reasons for these discrepancies. Firstly,
it is reasonable to expect that the preparation of total
RNA or construction of microarrays can vary significantly,
thereby influencing the outcome on transcriptional ana-
lysis. Secondly, different media and cultivation conditions
were applied, which clearly have effect on secondary me-
tabolism and differentiation. Finally, the discrepancies be-
tween different studies might be related to the fact that
due to the lack of pathway-specific regulation, erythro-
mycin biosynthesis is regulated directly through globally
acting regulatory elements which at the same time also
control morphological differentiation of S. erythraea.
Therefore, differential expression of multiple regulatory
genes might play a key role in increased erythromycin
yield in each individual high-producing strain, considering
that every strain was developed through an independent
media and process development in combination with clas-
sical mutagenesis and selection programs. Further experi-
ments are necessary in order to elucidate regulatorymechanisms by which SACE_5599 as well as bldD can
affect erythromycin yield. Interestingly, after the regulatory
network of BldD orthologue has been studied in signifi-
cant detail in Streptomyces coelicolor, the actinomycete
model organism [23,24,42,43], a more complex relation-
ship between BldD expression and erythromycin biosyn-
thesis in S. erythraea has been recently suggested [24].
Regardless of the poorly understood underlying regula-
tory and metabolic pathways, the S. erythraea production
strain and bioprocess for production of erythromycin have
been improved for over 50 years. A significant increase in
erythromycin yields has been achieved, compared to the
WT strain. However, considering the annual world pro-
duction and commercial importance of erythromycin and
its semi-synthetic derivatives, current yields remain rela-
tively low in comparison to other antibiotic production
technologies, e.g. tetracyclines or penicillin [44]. There-
fore, there is a clear commercial incentive to further im-
prove erythromycin production technology. In addition to
the classical methods of random mutagenesis and selec-
tion, which have been already exhausted to great extent,
metabolic and biosynthetic engineering are now expected
to have a key role in future improvement strategies. For
example, engineering the methylmalonyl-CoA mutase
(mcm) enzymatic activity has been shown to have good
potential for increasing the flux through the feeder path-
way of methylmalonyl-CoA, the main precursor of the
erythromycin polyketide chain. Inactivation of mcm lead
to yield increase in carbohydrate-based medium and over-
expression of the mcm operon enabled significant yield in-
crease in an oil based medium [11,45].
To our knowledge, improvement of erythromycin titres
by manipulation of expression of regulatory genes has so
far not been demonstrated. In this work we show that
using a comparative proteomic approach combined with
an extra effort to cultivate S. erythraea in conditions simu-
lating the industrial setting, regulatory genes relevant for
increasing erythromycin yield in genetic engineering ap-
proaches can be identified. Interestingly, SACE_5599 could
also have been envisioned as a possible candidate gene
based on a very recent comparative transcriptomics study,
also carried out industrial media [41]. Our results thus
open new possibilities for increasing erythromycin yields
by overexpressing globally acting (pleiotropic) regulatory
genes involved in key processes of development and differ-
entiation. Specifically, approaches aimed at achieving
higher levels or optimum temporal control of in trans ex-
pression of SACE_5599 could result in further improved
yields. Further on, other candidate regulatory genes in S.
erythraea genome, identified by recent omics analyses, car-
ried out in industrial conditions should be evaluated for
their potential of further improvement of the yield. Particu-
larly, regulators providing further yield increase in indus-
trial high-producing strains would be desirable for
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expression of regulatory genes will become a complemen-
tary strategy to manipulation of metabolic genes which has
already led to significant improvements of erythromycin
yields.
Conclusions
In conclusion, we have identified a new putative regulatory
gene SACE_5599 in S. erythraea that influences sporulation
during the life cycle of this actinomycete and importantly
affects erythromycin yield of the WTand high-producing S.
erythraea strains. While the detailed regulatory mecha-
nisms of this protein remain to be elucidated, we have ob-
served that erythromycin biosynthesis and final yield in S.
erythraea are strongly interrelated with regulatory networks
involved in morphological differentiation. We have also
shown that overexpression of SACE_5599 and bldD gene
(SACE 2077) can improve the yield of erythromycin in the
S. erythraea WT strain, suggesting that modulation of ex-
pression of globally acting regulators may lead to improved
producers of polyketide natural products. Importantly we
have shown, that omics approaches are valuable tools to
identify industrially relevant regulatory genes, however, it is
of key importance that samples for omics analysis are col-
lected in conditions which simulate real industrial setting.
Materials and methods
Cultivation and transformation of S. erythraea strains
The S. erythraea NRRL23338 type strain and ABE1441
industrial overproducing strain, obtained by iterative
methods of classical mutagenesis and selection, were
propagated on ABSM4 agar plates (1% corn starch, 1.1%
corn steep liquor, 0.3% (NH4)2SO4, 0.3% NaCl, 0.3%
CaCO3, 2% agar) or R5 agar plates [46] for 14-days at 30°C.
Laboratory scale fermentation in liquid culture was carried
out for estimation of erythromycin productivity. Seed cul-
tures were prepared in the ABVM1 medium (3% corn steep
liquor, 3% sucrose, 0.4% (NH4)2SO4, 0.6% CaCO3) at 30°C
and 220 rpm for 48 h at 6 mL or 40 mL of working volume
in Falcon tubes or Erlenmeyer flasks. Erythromycin pro-
duction phase was carried out in the ABPM8 medium
(3.6% soybean flour, 3.6% corn starch, 0.24% (NH4)
2SO4, 0.72% CaCO3, 0.5% soybean oil) inoculated with
10% (v/v) of the above seed culture. At time of inocula-
tion 2% glucose and 0.67% n-propanol were added. Cul-
tivations were performed at 5 mL or 25 mL working
volume at 30°C and 220 rpm for 7 days. After 24 h of
cultivation 1% glucose and 0.34% n-propanol were
added. Apramycin (50 μg/ml) and thiostrepton (25 μg/
ml solid and 5 μg/ml liquid media) were added to the
solid and liquid media as required.
Seed cultures for the cultivation in bioreactors were pre-
pared as described above, using 400 ml of the ABVM1
seed medium in 2 L Erlenmeyer flasks. Fermentationexperiments were carried out in 5 L Bioreactors (Sartor-
ius) with 3.5 L of ABPM8 production medium, operated
at 30°C, 1 vvm airflow and 350–900 rpm agitation. Biore-
actors were inoculated with 10 vol.% seed culture. Dis-
solved oxygen concentration and pH were monitored
using autoclavable electrodes (Hamilton). Dissolved oxy-
gen was maintained above 20% with increasing agitation
and aeration rate during the bioprocess. Foaming was
controlled by automatic addition of antifoam. Samples for
RT-PCR and proteomic analysis were taken during the
bioprocess and stored at -80°C until analysis as described
below.
Transformation of S. erythraea strains was achieved by
conjugation of pSET152 [46] and pKC1132 [47] based plas-
mid constructs from the E. coli strain ET12567 carrying
the E. coli-Streptomyces conjugation facilitating plasmid
pUZ8002, as described previously [48]. Standard methods
for isolation and manipulation of DNA were used [32,46].
Bioinformatic methods
BlastP searches [26] were performed against the nr protein
database of NCBI (www.ncbi.nlm.nih.gov) using amino
acid sequence of SACE_5599 as query. Hits with E
value < 10-5 were considered to be homologous and
were aligned using ClustalW2 program with default pa-
rameters (www.ebi.ac.uk).Comparative proteomic analysis
Whole fermentation broth samples were centrifuged and
washed three times with 50 mM Tris–HCl, pH = 7.2.
Cells were resuspended in lysis buffer containing 7 M
urea, 2 M tiourea, 4% CHAPS, 40 mM Tris, 65 mM
DTT and complete protease inhibitor cocktail (Roche)
and subsequently sonicated. Homogenate was centri-
fuged to obtain cell extract. Proteins in the cell extract
were separated on a 12% precast SDS-PAGE gel (Lonza)
and stained using Coomassie Brilliant Blue dye. Whole
protein lanes were excised, sliced into bands and sub-
jected to the standard trypsin digestion procedure as
previously described [49]. Peptides were extracted from
the gel, and injected into nanoLC HPLC unit (Proxeon)
coupled with Orbitrap LTQ Velos mass spectrometer
(Thermo Scientific). Peptides were separated on a Pico-
frit C18 analytical column (New Objective) with a 90 mi-
nute linear gradient of 5-50% acetonitrile/0.1% formic
acid. MS/MS spectra were generated using CID frag-
mentation of precursor ions generated in the MS scans.
Protein identification and relative quantification by
spectral counting was carried out using MaxQuant data-
base search software [50] and species specific NCBI
database. For the database search Methionine oxidation
was set as variable and carbamidomethylation of cyste-
ines was set as fixed modification.
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Expression of SACE_5599 gene was monitored in the
time course of the fermentation process in WT,
ABE1441 and in overexpression strains. For SACE_5599
primers (F: CTGGATCGTGGCCAACCT, R: GGGCGCC
TCGACCTG) and TaqMan MGB probe (FAM- CTGGT
CGGCTTCCTCC -MGB) were designed by Life Tech-
nologies (Assay by Design service). 16S rRNA primers,
targeting SACE_8105, (F: ACTGAGACACGGCCCAG
ACT, R: AGGCTTKCGCCCATTGTG) and TaqManMGB
probe (FAM-CTGCTGCCTCCCGTAG-MGB), designed
in-house using Primer Express (Life Technologies), were
used for normalization.
RNA was isolated from 0.5 ml of fixated (ethanol:phe-
nol 96:4) culture. After removal of the fixative, the pellet
was treated with lysozyme (Sigma, 15 mg/ml) and pro-
teinase K (6000U, Qiagen) in TE buffer for 10 minutes,
followed by homogenization with a bead beater (Fas-
tPrep, Qbiogene) using Lysing Matrix B (Qbiogene)
beads and RLT Buffer (550 μl, Qiagen). Lysates were
centrifuged and supernatant was used for subsequent
RNA isolation using RNeasy Mini Kit (Qiagen, Hilden,
Germany) with following modifications of the manufac-
turer’s protocol: samples were washed with RW1 and
RPE buffer twice and three-times, respectively. RNA was
eluted with pre-heated (65°C) RNAse-free water follow-
ing 5 minute incubation. To remove remaining genomic
DNA, total RNA samples were treated in solution with
Qiagen’s RNase-free DNase digestion kit (Qiagen, 0.5 U/
μg RNA). Efficiency of DNase digestion was tested using
RT- controls. RNA quantity and quality was checked
using Nanodrop, gel electrophoresis and Bioanalyzer
(Agilent) Reverse transcription and qPCR analysis of
SACE_5599 and 16S rRNA was performed using Light-
Cycler 480 as described previously [51]. The standard
curve method was used for relative gene expression quan-
tification, and the transcript accumulation of SACE_5599
was normalized to 16S rRNA.
Overexpression of SACE_5599 and bldD genes
219 aa and 184 aa variants of SACE_5599 gene (Figure 3B)
were amplified using S. erythraea genomic DNA as tem-
plate. The shorter gene variant was amplified using the
following primers: forward primer AAAATATCATATG
AATTCGTCGGCCTGGTTCCTCGGTGAC introducing
NdeI restriction site into the start codon and reverse
primers AAAAATCTAGAATTATGCCCGGGCGACCAG
TTGCCGGTGCT and AAAAATCTAGAATTAGGCGT
AGTCCGGGACGTCGTACGGGTATGCCCGGGCGACC
AGTTGCCGGTGCT for HA-tagging of the protein, in
both cases introducing XbaI restriction site after the stop
codon. The 219 aa gene variant was amplified using the fol-
lowing forward primer: AAAAACATATGGAACGCTCCG
GTGAGGTGCTGGCG and the same reverse primers usedas for the 184 aa variant of the gene. The PCR amplified
genes were cloned into pSet152 vector into which the con-
stitutive PermE* promoter [52] was previously cloned, thus
creating series of pABE vectors (Table 1). The identity of
the PCR products was confirmed by sequencing. As the 5’-
UTR of the native ermE gene lacks obvious RBS, a variant
of the promoter sequence containing RBS [21] was also as-
sembled to achieve constitutive expression of SACE_5599.
The bldD gene was amplified using S. erythraea genomic
DNA as template using the following primers: forward pri-
mer AAAAAAACATATGGGCGACTACGCCAAGGCGC
TGGG introducing NdeI restriction site into the start
codon and reverse primer AAATCTAGACTCACTCC
TCCCGGGCCGGGCGC introducing XbaI restriction site
after the stop codon. As above, the PCR amplified gene was
cloned into pSet152 vector with PermE* promoter and con-
firmed by sequencing. The obtained plasmid constructs
were introduced into S. erythraea NRRL23338 strain using
standard conjugation procedure [46] and the insertion of
plasmid constructs into pseudo att site was confirmed by
PCR. The obtained independent colonies were cultivated
according to the above procedures and erythromycin yields
were estimated by the microbiological assay.
Inactivation of SACE_5599 in the ABE1441 strain
Gene disruption of SACE_5599 was carried out by trans-
formation of the ABE1441 strain with pKC1132 [47] based
plasmid construct containing an 344 bp central region of
the SACE_5599 gene (pABE110). The central region of
SACE_5599 was PCR amplified using the following
primers: d5599F AAAGAATTCGTCGGCCTGGTTCCT
CGGTGAC containing EcoRI restriction site at 5’-end and
d5599R AAAAAAGCTTTGGTCACCTGGATGGCGGG
CATC containing HindIII restriction site at 5’-end. The
PCR fragment was gel purified, digested with EcoRI and
HindIII enzymes and cloned into pKC1132 vector opened
with the same enzymes to generate pKC1132-d5599
plasmid construct (pABE110). The correct nucleotide se-
quence was confirmed by sequencing. The pKC1132-
d5599 was transformed into the ABE1441 strain using
standard conjugation procedure described previously [46]
and SACE_5599 gene was inactivated through a single-
crossover recombination event. Inactivation of SACE_5599
in 20 independent apramycin-resistant ex-conjugants was
confirmed by PCR and sequencing. The obtained inde-
pendent colonies were cultivated according to the above
procedures and erythromycin yields were estimated by
HPLC.
Complementation of SACE_5599 in the mutant strain
S. erythraea OP (ΔSACE_5599) was carried out by inser-
tion of vectors containing the 219 aa variant of the gene
under the control of PermE* promoter. The pABE112
vectors was constructed by inserting the thiostrepton re-
sistance marker [46] into the MscI restriction site of the
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taining the 219 aa variant of the SACE_5599 gene.
Detection and quantification of erythromycin in
fermentation broths
HPLC
After cultivation was completed, the pH of the broth
was first adjusted to 9.5-10 and the broth was mixed
with the equal volume of acetonitrile (1:1) for 40 min.
After that 1 g NaCl was added per 5 g of broth, left to
dissolve and the acetonitrile phase was then separated
by centrifugation and applied onto the Nucleodur HTec
C18, 3 μm (150 × 4.6 mm, Macherey-Nagel, Dueren,
Germany) reversed-phase stationary phase HPLC column
installed on the Thermo Finnigan Surveyor +HPLC sys-
tem. Isocratic elution was applied with mobile phase pre-
pared from 20% 50 mM K2HPO4 with pH adjusted to 9
with diluted phosphoric acid and 80% acetonitrile. After
injection of 10 ul of the sample solution, the HPLC system
was operated at a flow rate of 1 ml / min, with total the
run time of 30 minutes. The column temperature was set
at 60°C and the detection wavelength at 206 nm. Refer-
ence substance erythromycin A was obtained from the
European Pharmacopoeia and was 98.4% pure. Standard
solution was prepared by dissolving 5 mg of erythromycin
in 5 mL of solvent. All chemicals used were HPLC-grade.
Growth inhibition assay
The titres of erythromycin produced by S. erythraera
NRRL23338 strain and its genetically modified variants
were determined using a conventional Pharmacopoeia
bioassay method (European Pharmacopoeia 5.0). As
standard commercially available eythromycin (Calbio-
chem) was used and Bacillus subtilis NRRL B-765 strain
was grown as test organism. Samples were extracted in
acetonitrile and 60 μL of properly diluted extracts were
transferred in cylinder halls on ABA agar test medium
(Biolife) which contained overnight Bacillus subtilis cul-
ture. The plates were incubated for 14 – 16 h at 37°C.
Thereafter, sizes of inhibition zones were measured and
erythromycin concentrations calculated according the
standard curve. The method has a linear response in the
range from 1 mg/L to 20 mg/L and all samples were di-
luted accordingly.
Statistical analysis
Yields of erythromycin were calculated with SAS/STAT
software using means and the univariate procedure to
test the normality of distribution. Using the GLM model,
data were calculated as least mean square and are pre-
sented as an average change observed from all experi-
ments when comparing least mean square values to the
wild-type control least mean square value of each
experiment.SDS PAGE and western blotting
Cell-free protein extracts of S. erythraea were prepared
by washing the cells in 100 mM K-phosphate buffer, pH=
7.4 twice, resuspending in the same buffer containing
complete protease inhibitor cocktail (Roche) and subse-
quent sonification. A total of 50 μg of proteins were boiled
in Laemmli’s sample buffer. Proteins were separated on a
15% SDS-PAGE gel and transferred to a nitrocellulose
membrane. Immunodetection was performed with mono-
clonal rat anti-HA primary antibodies (Roche) and horse-
radish peroxidase conjugated anti-rat secondary antibodies
(Calbiochem). The antigens were visualized with chemolu-
miniscence detection system (GE Healthcare).Additional files
Additional file 1: Figure S1. Differences in sporulation intensity of the
S. erythraea strains on ABSM4 (A) and R5 (B) agar medium (Kieser et al.,
2000 [46]). The ABE1441 strain is plated on the upper half and the
NRRL23338 WT strain is plated on the lower half of both plates.
Additional file 2: Table S1. Proteomic identification of SACE_5599 in
erythromycin overproducing ABE1441 strain. Table A shows the list of
identified peptides with their corresponding peptide mass, Posterior Error
Probability (PEP) and Maxquant peptide score. Table B shows peptide
spectral counts obtained from the analysis of the WT (NRRL23338) and
industrial strain (ABE1441). Experiment was done in two biological
replicates.
Additional file 3: Figure S2. Protein sequence alignment of SACE_5599
family of proteins (ClustalW2). Conserved tryptophan residues are marked in
red and conserved arginine residues are marked in blue. Central region of
the protein, showing particularly high sequence similarity among all
homologues, is marked in grey. Homologues from selected Actinomycetales
species are presented: Slin – LmbU from S. lincolnensis; W007 – LmbU from
Streptomyces sp. W007; Sery – SACE_5599 from S. erythraea; Shim – HmtD
from Streptomyces himastatinicus ATCC53653 ; Stsu – Streptomyces
tsukubaensis NRRL18488; Faln – Frankia alni ACN14a; K744 – Orf10 from
Kutzneria sp. 744; Scae – NovE from Streptomyces spheroides; Sgri – HrmB
from Streptomyces griseoflavus; Scla – Streptomyces clavuligerus ATCC27064.Abbreviations
Aa: Amino acid; Bp: Base pair; GC-rich: Containing high proportion of
guanosine and cytosine bases; Mcm: Methylmalonyl-CoA mutase; ORF: Open
reading frame; PCV: Packed cell volume; RBS: Ribosomal binding site;
UTR: Untranslated region; WT: Wild type.Competing interests
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